Wealth Enhancement Advisory Services
RGNX icon

Wealth Enhancement Advisory Services’s Regenxbio RGNX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$629K Buy
45,090
+630
+1% +$5.23K ﹤0.01% 2472
2026
Q1 		$379K Buy
44,460
+31
+0.1% +$326 ﹤0.01% 2560
2025
Q4 		$630K Buy
44,429
+5,115
+13% +$63.8K ﹤0.01% 2303
2025
Q3 		$413K Buy
39,314
+8,684
+28% +$76.8K ﹤0.01% 2524
2025
Q2 		$268K Buy
30,630
+13,458
+78% +$113K ﹤0.01% 2733
2025
Q1 		$123K Buy
+17,172
New +$128K ﹤0.01% 2728

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Wealth Enhancement Advisory Services's RGNX Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Regenxbio (RGNX) stake by 1.4% in Q2 2026, buying an estimated $5.23K and bringing the position to 45,090 shares worth $629K. The position accounts for ﹤0.01% of the portfolio, ranked #2472.

Wealth Enhancement Advisory Services first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $630K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Wealth Enhancement Advisory Services held 45,090 shares of Regenxbio worth $629K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 630 Regenxbio shares in Q2 2026, an estimated $5.23K.
  • Regenxbio made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2472 holding.
  • Wealth Enhancement Advisory Services first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • Wealth Enhancement Advisory Services's Regenxbio position peaked at $630K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.